Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib.

Jonghwa Ahn Eyun Song Won Gu Kim Tae Yong Kim Won Bae KimYoung Kee ShongMin Ji Jeon

Published in: Clinical endocrinology (2019)

A low LMR was associated with poor response rate, PFS and OS in patients with progressive RAIR DTC treated with sorafenib. Thus, LMR could be a simple prognostic biomarker in patients with progressive RAIR DTC.

Keyphrases

multiple sclerosis
peripheral blood
dendritic cells
newly diagnosed
immune response